TiGenix provides update on proposed initial public offering in the United States
/
Date26 Oct 2016
Leuven, Belgium, Oct. 26, 2016 (GLOBE NEWSWIRE) — TiGenix NV (Euronext Brussels: TIG; the “Company”), an advanced biopharmaceutical company focused on developing and commercializing novel... Read More →
Proteostasis Therapeutics Announces Conference Call to Provide Clinical and Scientific Update at 30th Annual North American Cystic Fibrosis Conference
/
Date26 Oct 2016
CAMBRIDGE, Mass., Oct. 26, 2016 (GLOBE NEWSWIRE) — Proteostasis Therapeutics, Inc. (NASDAQ:PTI), a biopharmaceutical company developing small molecule therapeutics to treat diseases caused by dysfunctional... Read More →
TiGenix publishes transparency notifications pursuant to Article 14 of the Law of May 2, 2007
/
Date26 Oct 2016
Leuven, Belgium, Oct. 26, 2016 (GLOBE NEWSWIRE) — TiGenix NV (Euronext Brussels: TIG) announced today that it received two transparency notifications pursuant to Article 14, first paragraph... Read More →
BioCryst Announces Late Breaker Presentation of Galidesivir (BCX4430) Nonclinical Results in Zika Virus Infection at IDWeek 2016
/
Date26 Oct 2016
RESEARCH TRIANGLE PARK, N.C., Oct. 26, 2016 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced that results from a study of galidesivir (formerly BCX4430)... Read More →
Drug Prevention Organizations Consider Legal Action to Stop Prop 64 and Any Further Proliferation of Marijuana
/
Date26 Oct 2016
Lincoln, CA, Oct. 26, 2016 (GLOBE NEWSWIRE) — “PROP 64 has the potential to destroy this state and nation,” according to Roger Morgan, Founder of... Read More →
Myriad’s BRACAnalysis CDx® Test Identifies Patients with Ovarian Cancer Who Would Benefit from Second-Line Maintenance Treatment with Olaparib
/
Date26 Oct 2016
SALT LAKE CITY, Oct. 26, 2016 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in molecular diagnostics and personalized medicine, today announced that its... Read More →
Miracle Flights Receives $25,000 Donation from TeamHealth
/
Date26 Oct 2016
LAS VEGAS, Oct. 26, 2016 (GLOBE NEWSWIRE) — Miracle Flights, the nation’s foremost medical flight charity, is thrilled to be awarded a $25,000 donation from... Read More →
Auven Therapeutics Announces Sale of Ocular Technologies to Sun Pharma
/
Date26 Oct 2016
Ocular Technologies’ key development program asset, SecieraTM for the treatment of dry eye disease, is close to completing confirmatory Phase 3 clinical trial Auven to... Read More →
INNATE PHARMA : Encouraging initial results for IPH4102 presented at the Third World Congress of Cutaneous Lymphomas
/
Date26 Oct 2016
Preliminary data from the dose-escalation part of an ongoing Phase I trial in elderly and heavily pretreated patients including a majority of patients with Sezary... Read More →
Kessler Foundation Seeks Children and Adolescents for Brain Injury and Autism Research
/
Date26 Oct 2016
EAST HANOVER, N.J., Oct. 26, 2016 (GLOBE NEWSWIRE) — Kessler Foundation, a global leader in rehabilitation research, and Children’s Specialized Hospital, the nation’s leading provider... Read More →